- Home
- A-Z Publications
- Current Clinical Pharmacology
- Previous Issues
- Volume 14, Issue 1, 2019
Current Clinical Pharmacology - Volume 14, Issue 1, 2019
Volume 14, Issue 1, 2019
-
-
Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction
Authors: Stefano Omboni and Claudio BorghiHypertension and kidney disease often coexist, further increasing the risk of future cardiovascular events. Treatment of hypertensive adults with an angiotensin converting enzyme inhibitor in case of concomitant kidney disease may slow disease progression. The third-generation liphophilic angiotensin converting enzyme inhibitor zofenopril, administered alone or combined with a thiazide diuretic, has proved to be effective i Read More
-
-
-
Biosimilars: An Approach to some Current Worldwide Regulation Frameworks
Authors: Efraín Esteban, Rosa-Helena Bustos, Julio-César García and Edwin JáureguiDeveloping new biologics has led to regulations and norms aimed at guaranteeing their safety, quality and effectiveness, in terms of marketing, prescription, use, interchangeability and switching. Biologics are of great importance in treating patients suffering from rheumatic, autoimmune, inflammatory and neoplastic diseases. The expiry/lapse of reference biologics or originators’ patents has meant that developing biosimil Read More
-
-
-
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Authors: Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed E. Musa, Masoud Najafi and Bagher FarhoodBackground: Nowadays, ionizing radiation is used for several applications in medicine, industry, agriculture, and nuclear power generation. Besides the beneficial roles of ionizing radiation, there are some concerns about accidental exposure to radioactive sources. The threat posed by its use in terrorism is of global concern. Furthermore, there are several side effects to normal organs for patients who had undergone radiation tr Read More
-
-
-
Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions
Authors: Claudio D. Gonzalez, Jorge Alvariñas, Maria F.G. Bagnes and Guillermo Di GirolamoBackground: Metformin is sometimes used as an alternative to insulin in gestational diabetes mellitus (GDM). It is also used to achieve ovulation in polycystic ovary syndrome (PCOS). Pre-natal exposure to metformin results from its continuation after a successful ovulation in women with PCOS, its maintenance in women with pre-gestational diabetes or the installation of metformin in GDM. Little is known about the potential cons Read More
-
-
-
Role of Nrf2/HO-1 and PI3K/Akt Genes in the Hepatoprotective Effect of Cilostazol
Background: Cilostazol, a phosphodiesterase 3 inhibitor (PDE3I), is a platelet aggregation inhibitor and vasodilator that is useful for treating intermittent claudication. Experimental studies have shown that cilostazol has potent anti-inflammatory, anti-oxidant effects effects. Objectives: Although the hepatoprotective effect cilostazol has been studied, the molecular mechanisms of such protection, including: the nuclear f Read More
-
-
-
Pycnogenol Protects against Pentylenetetrazole-Induced Oxidative Stress and Seizures in Mice
Authors: Radha Goel and Prasoon SaxenaBackground: Epilepsy is one of the most common and severe brain disorders in the world, characterized by recurrent spontaneous seizures due to an imbalance between cerebral excitability and inhibition. Oxidative stress is a biochemical state in which reactive oxygen species are generated and associated with various diseases including epilepsy. Pycnogenol, a polyphenol obtained from the pine tree and has antioxidant& anti Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/ccp
Journal
10
5
false
en
